ARTICLE | Clinical News
Vanoxerine: Phase IIb data
December 9, 2013 8:00 AM UTC
The double-blind, Israeli and Russian Phase IIb COR-ART trial in 104 patients with symptomatic AF or flutter of recent onset showed that single oral doses of GBR-12909 reduced time to conversion to no...